Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | Stents Drug Eluting | October 11, 2019

Supraflex Drug-Eluting Stent Superior to Xience in Two-Year Target Vessel Failure

October 11, 2019 — The ultra-thin Supraflex drug-...

Videos | Antiplatelet and Anticoagulation Therapies | October 11, 2019

VIDEO: Early Discontinuation of DAPT in High Bleeding Risk Patients With the Synergy Stent

Ajay J. Kirtane, M.D., associate...

An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no statistically significant mortality increase. This was one of the first major reviews of trial data for patients who were treated with a paclitaxel coated device used in peripheral vessels following a meta analysis study of paclitaxel device trials published in December 2018 that showed a mortality safety signal. This was a major discussion during the FDA townhall meeting at the #TCT2019.

News | Drug-Eluting Balloons | October 10, 2019

LEVANT Trial Data Shows Safety of Drug-Coated Balloon Shown

October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no...

Videos | Antiplatelet and Anticoagulation Therapies | October 10, 2019

VIDEO: TWILIGHT Trial Shows Benefit to Ticagrelor Monotherapy After Stent Implantation

Roxana Mehran, M.D.,...

Feature | TCT | October 11, 2019

TCT 2019 Late-breaking Presentations

October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-...

News | Angiography | October 09, 2019

Canon Medical Launches Alphenix Encore Plus Program

October 9, 2019 — In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-...

Technology | Blood Testing | October 09, 2019

FDA Clears Abbott's High Sensitivity Troponin-I Blood Test

October 9, 2019 — Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has...

Videos | Heart Valve Technology | October 09, 2019

VIDEO: The Expansion of TAVR Following the FDA Clearing its Use in All Patients

Torsten...

News | Stent Grafts | October 09, 2019

FDA Grants Breakthrough Device Designation for Valiant Thoracoabdominal Aortic Aneurysm Stent Graft

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and...

$Medtronic is recalling the 6 French Sherpa NX Active Guide Catheter due to a risk of the outer material separating from the device resulting in detached fragments that could result in the underlying stainless-steel braid wires being exposed. These fragments could be left inside the patient’s bloodstream, and this or the attempts made to retrieve the fractured pieces, can cause other serious adverse health consequences such as continued blockage of blood vessels, injury to blood vessel walls, development of$